• A sero- prevalence survey was conducted in 2 endemic villages in Daraa, Syrian Arab Republic, where 80 out of 345 children (23.2%) tested positive for visceral leishmaniasis (VL) using rK39 dipstick test. (who.int)
  • Epidemiological aspects of canine visceral leishmaniosis in the Islamic Republic of Iran. (ac.ir)
  • 1 ]. While a mi- present study was made on infants, who are nority of infected individuals develops full- more commonly affected by visceral leish- blown visceral leishmanaisis, characterized maniasis in the Islamic Republic of Iran due by fever, hepatosplenomegaly, anaemia, to infection with L. infantum . (who.int)
  • Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. (nih.gov)
  • Iran is one of the endemic areas of Mediterranean Visceral Leishmaniasis, a disease caused by Leishmania infantum . (ac.ir)
  • The efficacy of PQ10 for serodiagnosis was evaluated with 50 positive and 50 negative serum samples, which confirmed by the direct agglutination test and collected from individuals living in the visceral leishmaniasis endemic areas of Iran. (ac.ir)
  • The increased prevalence of leishmaniasis in dogs in Mediterranean countries has necessitated use of a reliable specific method of immunodiagnosis. (nih.gov)
  • Direct quantitative relationships between prevalence of leishmaniasis in local dog populations and incidence of human disease have been reported ( 4 ). (cdc.gov)
  • 3. Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum. (nih.gov)
  • 9. Performance of rK39-based immunochromatographic rapid diagnostic test for serodiagnosis of visceral leishmaniasis using whole blood, serum and oral fluid. (nih.gov)
  • 2. Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis. (nih.gov)
  • 15. Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis. (nih.gov)
  • Employing bovine submaxillary mucin (BSM) as the coating agent, an enzyme-linked immunosorbent assay (BSM-ELISA) was developed to detect antibodies directed against O-acetylated sialic acids (O-AcSA) in canine visceral leishmaniasis (CVL). (huji.ac.il)
  • Sarkari B, Chance M, Hommel M. A capture ELISA for the diagnosis of visceral leishmaniasis using a monoclonal antibody against a leishmanial. (ac.ir)
  • Non-invasive following data were recorded: age, sex, serological methods such as immunofluo- place of residence, history of visceral leish- rescent antibody (IFA) and enzyme-linked maniasis in the area, adjacent health centre immunosorbent assay (ELISA) are and grandfather's name. (who.int)
  • 24- Serodiagnosis of Entamoeba histolytica by ELISA. (edu.iq)
  • 1. False Positivity of rK39 Test in Five Chronic Myeloid Leukemia Cases from Bihar, India: A Possible Challenge to Leishmaniasis Diagnosis. (nih.gov)
  • 5. Rapid screening with a recombinant antigen (rK39) for diagnosis of visceral leishmaniasis using dipstick. (nih.gov)
  • 14. Evaluation of an rK39-based immunochromatographic test for the diagnosis of visceral leishmaniasis in human saliva. (nih.gov)
  • 16. Enzyme-linked immunosorbent assay for recombinant K39 antigen in diagnosis and prognosis of Indian visceral leishmaniasis. (nih.gov)
  • In this work, we examined whether Proteína quimérica 10 (PQ10) recombinant protein is suitable for immunological diagnosis of human visceral leishmaniasis. (ac.ir)
  • Visceral leishmaniasis in Iran and the role of serological tests in diagnosis and epidemiological studies. (ac.ir)
  • Application of direct agglutination test (DAT) for the diagnosis and seroepide-miological studies of visceral leishmaniasis in Iran. (ac.ir)
  • Motazedian M, Fakhar M, Motazedian MH, Hatam G, Mikaeili F. A urine-based polymerase chain reaction method for the diagnosis of visceral leishmaniasis in immunocompetent patients. (ac.ir)
  • Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. (ac.ir)
  • For decades, definite diagnosis of were patients with hepatosplenomegaly, visceral leishmaniasis has required in- fever, anaemia (with or without neutropae- vasive procedures to find the parasite in nia) or hypergammaglubolinaemia who had the organs, such as spleen, bone marrow, been referred from endemic regions. (who.int)
  • 2009). Evaluation of Leishmania species reactivity in human serologic diagnosis of leishmaniasis . (up.pt)
  • A control group of children with other diagnoses (tuberculosis, toxoplasmosis, systemic lupus erythematosus, malaria or cutaneous leishmaniasis) were also tested to check false positive results. (who.int)
  • 8-Cutaneous leishmaniasis at Wasit Governorate. (edu.iq)
  • 27- Comparison of Diagnostic Methods in Cutaneous Leishmaniasis in Iraq. (edu.iq)
  • 31- Cutaneous Leishmaniasis in Iraq: A clinicoepidemiological descriptive study. (edu.iq)
  • 33- Some Epidemiological Aspects of Cutaneous Leishmaniasis in Kut city, Iraq. (edu.iq)
  • 8. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. (nih.gov)
  • 17. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. (nih.gov)
  • We have used a recombinant synthetic protein to improve serodiagnosis of human visceral leishmaniasis. (ac.ir)
  • 12. Performance of a rapid diagnostic test for the detection of visceral leishmaniasis in a large urban setting. (nih.gov)
  • Visceral (the usual laboratory method at this centre) leishmaniasis is endemic in the south of the in the detection of visceral leishmaniasis. (who.int)
  • Background Visceral leishmaniasis (VL) is a major neglected disease, potentially fatal, whose control is still impaired by inefficient and/or expensive treatment and diagnostic methods. (scite.ai)
  • Informed consent sensitive methods of diagnosing visceral was obtained from the parents of all patients leishmaniasis [ 6-8 ], but they require fluo- before the study started. (who.int)
  • Samples for direct agglutination test (DAT) leishmaniasis by 3 different methods: light can be easily obtained, but must be sent microscopy of bone marrow aspirate to distant medical centres [ 9 ]. (who.int)
  • However, sporadic cases of leishmaniasis have been reported in foxhounds and dogs of other breeds with no history of travel to areas where leishmaniasis was enzootic, and the origin of these infections remains unknown ( 7 , 8 ). (cdc.gov)
  • At that time, autochthonous leishmaniasis had not been reported in dogs, other animals, or humans in New York. (cdc.gov)
  • 7. Latent class analysis of diagnostic tests for visceral leishmaniasis in Brazil. (nih.gov)
  • 10. Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study. (nih.gov)
  • 11. Pediatric visceral leishmaniasis: a retrospective study to propose the diagnostic tests algorithm in southern Iran. (nih.gov)
  • Mohebali M. Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features. (ac.ir)
  • 2016). Interleukin-27 early impacts Leishmania infantum infection in mice and correlates with active visceral disease in humans . (up.pt)
  • Une enquête de séroprévalence a été réalisée dans 2 villages d'endémie à Dera (République arabe syrienne) où 80 enfants sur 345 (23,2 %) ont été testés positifs à la leishmaniose viscérale en utilisant le test rapide sur bandelette réactive rK39. (who.int)
  • Le test sur bandelette au rK39 est fiable en l'absence de moyens de laboratoire. (who.int)
  • 100 000-500 000 cases of visceral leish- da. (who.int)
  • Control of the leishmaniases. (ac.ir)
  • 18. Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis. (nih.gov)
  • Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. (ac.ir)
  • We describe the results of the 3-year investigation of canine visceral leishmaniasis in the United States and Canada through February 2003. (cdc.gov)